Literature DB >> 1654426

Spatial requirements of the Na channel binding site for class I antiarrhythmics as derived from the crystal structures of 4-substituted 2,6-bis(1-pyrrolidinylmethyl)phenols.

M L Główka1, R L Dargie, P W Codding.   

Abstract

The molecular structures of four class I antiarrhythmic agents containing a bis(1-pyrrolidinylmethyl)phenol framework were determined by X-ray diffraction methods and their conformations were analyzed by molecular mechanics. Each structure has an intramolecular hydrogen bond between the phenol OH group and one pyrrolidine N atom; this bond determines the orientation of the pyrrolidine ring. Only two distinct orientations are observed for the other pyrrolidine ring; the combination of the pyrrolidine ring positions produces molecular conformers that either have the two N atoms on the same side of the phenol ring plane or have the N atoms nearly coplanar with the phenol ring. Crystallographic conformations of benzamides as well as those calculated with molecular mechanics find a preferred conformation that has the three planar regions tilted by ca. 30 degrees with respect to one another. The combined restrictions of the hydrogen bond, the conformational preferences for the bis(pyrrolidinylmethyl)phenol moiety, and a consistent conformation for the central benzamide portion provide a suggestion of the active shape of class Ic antiarrhythmic drugs. The distance between two potential recognition groups--a phenyl ring (lipophilic group) separated by 3.8 A from an oxygen atom and a secondary or tertiary amine--is found to be unique for class Ic antiarrhythmics as compared to other class I antiarrhythmics, such as lidocaine, quinidine, procainamide, and disopyramide, and suggests a correlation between the molecular structures and the activity of class I antiarrhythmics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654426     DOI: 10.1021/jm00113a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.

Authors:  M K Pugsley; E J Yu; A L Goldin
Journal:  Exp Clin Cardiol       Date:  2001
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.